<p>Arrows with numbers below X-axis indicate time of initiation of antiretroviral therapy with RT inhibitors PMPA and FTC, and integrase inhibitor L-870812 (weeks 7 p.i.), addition of integrase inhibitor L-900564 (week 22 p.i.), and protease inhibitor Darunavir with boosting agent Ritonavir (week 30 p.i.). Grey shading shows the period of cART and the red dashed area indicates 3 weeks of SAHA therapy initiated 49 weeks post infection. The limit of detection by standard qRT-PCR is 30 copy Eq/ml (solid line) and ultrasensitive qRT-PCR is 15 copy Eq/ml (dashed line) or 4 copy Eq/ml (dotted line) attained when using larger volumes of plasma. Filled symbols show determined values, and open symbols indicate samples that were below the limit of de...
Objective(s): Suppression of viral replication in patients on antiretroviral therapy (ART) is determ...
<p>The light yellow highlighted region encompass the HIV-1 viral load measurements used to calculate...
<p>(A) Plasma viral loads (SIV <i>gag</i> RNA copies/ml plasma) determined as described previously [...
<p>Plasma viral loads were determined by TaqMan RT-qPCR using our standard viral load assay. All RMs...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
Objective: To determine markers that are associated with the durability of virologic response to the...
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
<p>Plasma viral load in RNA copies/ml is plotted on a log<sub>10</sub> scale along the left vertical...
<p>(RT = Cavidi reverse transcriptase (RT) assay, Roche RNA PCR, and bDNA = branched DNA assay).</p
To compare early decrease of HIV plasma viral load (pVL) after two standard combinations of highly a...
<p>CD8<sup>+</sup> cell-mediated inhibition of viral replication (red dashed line) and viral RNA cop...
Introduction: The goal of antiretroviral treatment (ART) in HIV-1 infection is the permanent suppres...
(A) Chronic 251 cohort (n = 6) assessed. (B) Kinetics of plasma (red lines) and CSF (blue lines) vir...
This study was designed to examine the relationship between untimed antiretroviral concentrations me...
<p>Top panel shows Kaplan-Meyer plot summarizing time to a viral load of more than 5,000 copies/ml i...
Objective(s): Suppression of viral replication in patients on antiretroviral therapy (ART) is determ...
<p>The light yellow highlighted region encompass the HIV-1 viral load measurements used to calculate...
<p>(A) Plasma viral loads (SIV <i>gag</i> RNA copies/ml plasma) determined as described previously [...
<p>Plasma viral loads were determined by TaqMan RT-qPCR using our standard viral load assay. All RMs...
(A) Plasma viral load (HIV-RNA copies/ml) was quantified in longitudinal plasma samples using a qRT-...
Objective: To determine markers that are associated with the durability of virologic response to the...
Analysis of number of days from antiretroviral therapy initiation to achieving suppressed viral load...
<p>Plasma viral load in RNA copies/ml is plotted on a log<sub>10</sub> scale along the left vertical...
<p>(RT = Cavidi reverse transcriptase (RT) assay, Roche RNA PCR, and bDNA = branched DNA assay).</p
To compare early decrease of HIV plasma viral load (pVL) after two standard combinations of highly a...
<p>CD8<sup>+</sup> cell-mediated inhibition of viral replication (red dashed line) and viral RNA cop...
Introduction: The goal of antiretroviral treatment (ART) in HIV-1 infection is the permanent suppres...
(A) Chronic 251 cohort (n = 6) assessed. (B) Kinetics of plasma (red lines) and CSF (blue lines) vir...
This study was designed to examine the relationship between untimed antiretroviral concentrations me...
<p>Top panel shows Kaplan-Meyer plot summarizing time to a viral load of more than 5,000 copies/ml i...
Objective(s): Suppression of viral replication in patients on antiretroviral therapy (ART) is determ...
<p>The light yellow highlighted region encompass the HIV-1 viral load measurements used to calculate...
<p>(A) Plasma viral loads (SIV <i>gag</i> RNA copies/ml plasma) determined as described previously [...